About Us

About Diabetes National Research GroupOur scientists have established scientific collaborations both internationally (Spain) and nationally (California, Louisiana and Vermont).  The number and range of collaborations with other diabetes scientists continues to grow. In the past 3 years, the scientists we support have published several scientific papers describing their results, sharing this information with others who specialize in these same fields.

Collaborations and scientific meetings such as these benefit hundreds to thousands of conference participants, scientists, anduniversity students. Scientists from throughout the world attend the conferences; therefore, indirectly, the services are made available to other scientists with whom the direct recipients collaborate, when they return to their home states and/or countries.

According to the National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK), the impact of diabetes is felt nationwide. In the United States, diabetes contributed to more than 193,000 deaths in 1996. Other factors such as disability payments, time lost from work and premature death equaled $54 billion; medical costs for diabetes care, including hospitalizations, medical care and treatment supplies totaled $44 billion. According to recent numbers, by the year 2025, the prevalence of diabetes in the United States is predicted to be 8.9 percent.

It is through our continued efforts and support that we strive to make discoveries and breakthroughs in treatments, and possible cures for diabetes.

Officers and Trustees

President Daniel Richey
C.F.O. Donald Cooper
Corporate Secretary Pamela Houghten
Assistant Corporate Secretary Mary Holmgren
TrusteeRichard A. Houghten, Ph.D.
Trustee Larry L. Pelton
Trustee Daniel Richey
TrusteeGeorge B. Thornton, Ph.D.
TrusteePatricia S. Wu, MBChB, FRCP(Edin), FACE